Stock GKOS GLAUKOS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Glaukos Corporation

Equities

GKOS

US3773221029

Real-time Estimate Cboe BZX
Other stock markets
 02:11:33 2024-05-15 pm EDT 		5-day change 1st Jan Change
113.4 USD +2.17% Intraday chart for Glaukos Corporation +6.13% +42.73%
May. 14 Glaukos Insider Sold Shares Worth $264,791, According to a Recent SEC Filing MT
May. 06 Jefferies Upgrades Glaukos to Buy From Hold, Raises Price Target to $125 From $84 MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Glaukos : Q1 2024 Earnings Transcript
PU
Glaukos : Q1 2024 GAAP to Non-GAAP Recs
PU
Glaukos : Q1 2024 Quarterly Summary
PU
Glaukos: Q1 Earnings Snapshot
AQ
Glaukos Announces First Quarter 2024 Financial Results
BU
Glaukos Announces the Release of its 2023 Sustainability Report
BU
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
BU
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
BU
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
BU
Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial, Demonstrating Industry-Leading Accuracy and Innovation in Visual Field Testing for Virtual Reality Perimetry
AQ
Celanese Announces Commercial Launch of Glaukos' iDose TR (Travoprost Intracameral Implant) using Celanese's VitalDose Ethylene Vinyl Acetate (EVA)
AQ
Glaukos : Q4 2023 Earnings Transcript
PU
Glaukos: Q4 Earnings Snapshot
AQ
Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
BU
Glaukos : Q4 2023 Quarterly Summary
PU
Glaukos : Q4 2023 GAAP to Non-GAAP Recs
PU
Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21
BU
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance
BU
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
BU
Glaukos Announces FDA Approval of iDoseTR
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GKOS Stock
  4. News Glaukos Corporation
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW